Success Stories
Self-reported health status and its predictors among people with diabetes..
Presented at ISPOR (2023) Authors: T. Arnaut, P. Cerletti, J. Laurent, N. Hermanns In this study, we aimed at measuring self-reported health status in people with..
Learn MorePrevalence and predictive factors of psychological distress among people with..
Presented at ISPOR (2023) Authors: P. Cerletti, T. Arnaut, J. Laurent, N. Hermanns High levels of diabetes distress can lead to reduced quality of life and..
Learn MorePatient-Drivent Outcome Selection (PDOS): a patient-focused approach for selecting outcomes..
Presented at ISPOR (2023) Authors: Lise Radoszycki, Emilie Pain, Cynthia Lesbros, Luis-Alejandro Gonzalez Patient-Reported Outcomes (PROs) are increasingly used to support the development and the evaluation..
Learn More
Meet EvidentIQ at SCOPE in Barcelona this October!
We are happy to attend the 6th annual SCOPE Europe that will take place in Barcelona from 17-18 October, 2023. This event brings together leaders..
Learn More
EvidentIQ is pleased to announce the addition of Asthenis GmbH..
We are proud to announce the acquisition of Asthenis GmbH, the market leader in cancer documentation software in the DACH region (Germany, Austria and Switzerland). ..
Learn More
What is the difference between CTMS and EDC?
Clinical trials are a crucial component of medical research, playing a pivotal role in advancing healthcare treatments and therapies. Over the years, tools like Clinical..
Learn MoreCannabis-based products and multiple sclerosis-related pain: The role of routes..
Published in Multiple Sclerosis and Related Disorders – 2023 Collaborators: INSERM Authors: Tangui Barré, Damien Testa, Clémence Ramier, Melina Santos, Fabienne Marcellin, Perrine Roux, Patrizia..
Learn More